. Erratum: Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non-Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA Trial. J Clin Oncol 2023 Apr 27:JCO2300658. doi: 10.1200/JCO.23.00658.
PMID: 37104731